-
1.Caffeinated compounds and compositions for treatment of amyloid diseases and synucleinopathies 有权
Title translation: 用于治疗淀粉样蛋白病和突触核蛋白病的咖啡因化合物和组合物公开(公告)号:US09169255B2
公开(公告)日:2015-10-27
申请号:US14238755
申请日:2012-10-10
Applicant: ProteoTech Inc
Inventor: Luke Esposito , Kelsey Hanson , Marisa C. Yadon , Thomas Lake , Alan D. Snow , Joel Cummings , Anil Kumar
IPC: C07D473/12 , C07D473/04 , C07D473/06 , C07D473/08 , C07D473/10
CPC classification number: C07D473/04 , C07D473/06 , C07D473/08 , C07D473/10 , C07D473/12
Abstract: Compounds and their pharmaceutically acceptable salts for treatment of β-amyloid diseases, such as observed in Alzheimer's disease and synucleinopathies, such as Parkinson's disease.
Abstract translation: 用于治疗淀粉样蛋白疾病的化合物及其药学上可接受的盐,例如在阿尔茨海默病和突触核蛋白病中观察到的,例如帕金森病。